Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.

ABSTRACT:

Background

Thiazolidinediones, commonly used antidiabetic medications, have been associated with an increased risk of development of diabetic macular oedema and increased vascular endothelial cell permeability. Macular neovascularisation in age-related macular degeneration (AMD) and associated fluid leakage may be influenced by thiazolidinediones. This study aims to determine the association between thiazolidinedione usage and retinal morphological outcomes or visual acuity (VA) in patients treated with bevacizumab or ranibizumab for neovascular AMD (nAMD).

Methods

Secondary analysis of data from the Comparison of Age-related Macular Degeneration Treatments Trials. Participant self-reported diabetes status and thiazolidinedione usage at baseline. VA, intraretinal, subretinal

SUBMITTER: Core JQ 

PROVIDER: S-EPMC10245276 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature